Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle

European Journal of Medicinal Chemistry

Volumn 97, Issue 1, 2015, Pages 732-746

  Raffa, Demetrio ^a   Maggio, Benedetta ^a   Raimondi, Maria Valeria ^a   Cascioferro, Stella ^a   Plescia, Fabiana ^a   Cancemi, Gabriella ^a   Daidone, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Bioactive system; heterocycle; Pyrazole fused with a five membered

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; HETEROCYCLIC COMPOUND; NITROGEN; OXYGEN; PYRAZOLE DERIVATIVE; SULFUR; PYRAZOLE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HYDROGEN BOND; MOLECULE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; PROCEDURES;

ANIMALS; DRUG DISCOVERY; HUMANS; PYRAZOLES;

EID: 84942077300     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.12.023     Document Type: Review

References (60)

1. R. Sridhar, P.T. Perumal, S. Etti, G. Shanmugam, M.N. Ponnuswamy, V.R. Prabavathy, N. Mathivanan, Design, synthesis and anti-microbial activity of 1H-pyrazolecarboxylates, Bioorg. Med. Chem. Lett. 4 (2004) 6035-6040.
2. D. Raffa, O. Migliara, B. Maggio, F. Plescia, S. Cascioferro, M.G. Cusimano, G. Tringale, C. Cannizzaro, F. Plescia, Pyrazolobenzotriazinones derivatives as COX inhibitors: synthesis biological activity and molecular modelling studies, Arch. Pharm. Chem. Life Sci. 10 (2010) 631-638.
3. M.D. Alt?ntop, A. Ozdemir, S. Ilg?n, O. Atli, Synthesis and biological evaluation of new pyrazole-based thiazolyl hydrazone derivatives as potential anticancer agents, Leet. Drug Des. Discov. 7 (2014) 833-839.
4. O.I. El-Sabbagh, M.M. Baraka, S.M. Ibrahim, P. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, A.A. Rashad, Synthesis and antiviral activity of new pyrazole and thiazole derivatives, Eur. J. Med. Chem. 44 (2009) 3746-3753.
5. M. Abdel-Aziz, A. El-Din, G. Abuo-Rahma, A.A. Hassan, Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities, Eur. J. Med. Chem. 44 (2009) 3480-3487.
6. Kumar, K. Kaur, G.K. Gupta, A.K. Sharma, Pyrazole containing natural products: synthetic preview and biological significance, Eur. J. Med. Chem. 69 (2013) 735-753.
7. A. Chauhan, P.K. Sharma, N. Kaushik, Pyrazole: a versatile moiety, Int. J. ChemTech Res. 3 (2011) 11-17.
8. F.K. Keter, J. Darkwa, Perspective: the potential of pyrazole-based compounds in medicine, Biometals 25 (2012) 9-21.
9. Meng Li, Bao-Xiang Zhao, Progress of the synthesis of condense d pyrazole derivatives (from 2010 to mid-2013), Eur. J. Med. Chem. 85 (2014) 311-340.
10. D. Fancelli, A. Isacchi, M. Modugno, J. Moll, L. Rusconi, C. Soncini, R. Lupi, Use of a kinase inhibitor for the treatment of particular resistant tumors, Patent WO2007113198 A2, October 11, 2007.
11. D. Fancelli, J. Moll, M. Pulici, F. Quartieri, T. Bandiera, 1H-thieno[2, 3-c]pyrazole compounds useful as kinase inhibitors, Patent WO2007009898 A1 January 25, 2007.
12. S. Bindi, D. Fancelli, C. Alli, D. Berta, J.A. Bertrand, A.D. Cameron, P. Cappella, G. Cervi, V. Croci, M. D'Anello, B. Forte, M.L. Giorgini, A. Marsiglio, J. Moll, E. Pesenti, V. Pittal-a, M. Pulici, F.R. Sirtori, F. Roletto, C. Soncini, P. Storici, M. Varasi, D. Volpi, P. Zugnoni, P. Vianello, Thieno[3, 2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity, Bioorg. Med. Chem. 18 (2010) 7113-7120, http://dx.doi.org/10.1016/j.bmc.2010.07.048.
13. D. Fancelli, S. Bindi, M. Varasi, P. Vianello, S. Vioglio, D. Tesei, Preparation of thieno[2, 3-c]pyrazole derivatives as protein kinase inhibitors, Patent WO 2005074922, 2005.
14. R. Tonani, S. Bindi, D. Fancelli, V. Pittala, M. Varasi, Condensed heterocyclic pyrazole derivatives as protein kinase inhibitors, Patent WO2004013146, 2004.
15. J.C. Carry, G. Doerflinger, A. Bigot, D. Barbalat Damour, F. Clerc. Substituted thieno [2,3]pyrazoles, method for the preparation thereof, compositions containing them and use thereof,Patent WO2006056697,2006
16. C. Barberis, J.C. Carry, G. Doerflinger, D. Barbalat Damour, F.F. Clerc, H. Minoux, Hydrazinocarbonyl-thieno[2, 3-c]pyrazoles, preparation method, compositions containing same and use,Patent WO2006092510.2006.[4, 3-d]thiazole derivatives, and preparation and therapeutic application thereof, Patent WO2008015340, 2008.
17. G. Doerflinger, J.C. Carry, Pyrazolo[4, 3-d]thiazole derivatives, and preparation and therapeutic application thereof, Patent WO2008015340, 2008.
18. I. Akritopoulou-Zanze, D. Darczak, K. Sarris, K.M. Phelan, J.R. Huth, D. Song, E.F. Johnson, Y. Jia, S.W. Djuric, Scaffold oriented synthesis. Part 1: design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors, Bioorg. Med. Chem. Lett. 16 (2006) 96-99, http://dx.doi.org/10.1016/j.bmcl.2005.09.042.
19. A. Bigot, F. Clerc, G. Doerflinger, S. Mignani, H. Minoux, Preparation of substituted thieno [2, 3-c]pyrazoles and their use as medicinal products for cancer and neurodegenerative diseases, Patent U. S.20050026984, 2005.
20. L. Chou, L. Huang, J. Yang, F. Lee, C. Teng, S. Kuo, Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents, Eur. J. Med. Chem. 15 (2007) 1732-1740.
21. J. Lee, L. Chou, J. Lien, J. Wu, C. Huang, C. Chung, F. Lee, L. Huang, S. Kuo, T. Way, CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of taxol in vitro and in vivo, Oncol. Rep. 30 (2013) 1762-1772.
22. L. Chou, L. Huang, M.-Hsu, M. fang, J. Yang, S. Zhuang, H. Lin, F. Lee, C. Teng, S. Kuo, Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3, 2-c] pyrazole derivatives as new anticancer agents, Eur. J. Med. Chem.
23. D. Yamashita, H. Lin, W. Wang, Inhibitors of Akt Activity, Patent WO2005085227 (A1), 2005.
24. W.-G. Su, H. Jia, G. Dai, Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor, Patent WO2011079804, 2011.
25. H. Jia, G. Dai, J. Weng, Z. Zhang, Q. Wang, F. Zhou, L. Jiao, Y. Cui, Y. Ren, S. Fan, J. Zhou, W. Qing, Y. Gu, J. Wang, Y. Sai, W. Su, Discovery of (S)-1-(1-(Imidazo [1, 2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H [1,2,3]triazolo [4, 5-b]pyrazine (Volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-met) inhibitor in clinical development for treatment of cancer, J. Med. Chem. 57 (2014) 7577-7589.
26. D.A. Williams, Compounds for treating Rac-GTPase mediated disorders, Patent WO2014059305, 2014.
27. R. Tonani, S. Bindi, D. Fancelli, V. Pittala', A.M. D', M. D'anello, Heterobicyclic pyrazole derivatives as kinase inhibitors, Patent US20060160874 (A1), 2006.
28. R. Tonani, S. Bindi, D. Fancelli, V. Pittala', M. D'anello, Heterobicyclic Pyrazole Derivatives as Kinase inhibitors, Patent WO2004007504 (A1), 2004.
29. D. Fancelli, M. Pulici, J. Moll, T. Bandiera, 1H-Furo [3, 2-C]pyrazole compounds useful as kinase inhibitors, Patent WO2007138017, 2007.
30. D. Fancelli, Pulici M., Cervi G., Quartieri F., Vianello P., 1H-Furo[3, 2-C]pyrazoles active as aurora kinase inhibitors, Patent EP2058215, 2009.
31. P. Bounaud, A. Vaino, Bicyclic pyrazolo-fused compound as protein kinase modulators, Patent WO2005068473, 2005.
32. P.Y. Bounaud, S. Hopkins, E. Jefferson, M. Wilson, M. Wong, T. Kanouni, Pyrazolothiazole Protein Kinase Modulators, Patent WO2007059341, 2007.
33. Chong, Wesley Kwan Mung; Duvadie, Rohit Kumar, Preparation of 5-amino-3-substituted-pyrazolo [4, 5-d]thiazole compounds as inhibitors of cyclindependent kinases Patent, WO 2002012250,2002.
34. T. Mustelin; L. Tauts; N.D.P. Cosford; E. Sergienko, Method for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating, Patent US 20090105240, 2009.
35. H. Yu, Y. Jung, H. Kim, J. Lee, C.H. Oh, K. Ho Yoo, T. Sim, J.M. Hah, 1, 4-Dihydropyrazolo [4, 3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors, Biorganic& Med. Chem. Lett. 20 (2010) 3805-3808.
36. S. Manfredini, C.B. Vicentini, M. Manfrini, N. Bianchi, C. Rutigliano, C. Mischiati, R. Gambari, Pyrazolo-triazoles as light activable DNA cleaving agents, Bioorg. Med. Chem. 8 (2000) 2343-2346.
37. S. Bolgunas, D.A. Clark, W.S. Hanna, P.A. Mauvais, S.O.Pember, Potent inhibitors of the Qi site of the mitochondrial respiration complex III, J. Med. Chem. 49 (2006) 4762-4766.
38. S.T. Rabie, M.M. Abdelhalim, N.R. Mohamed, Synthesis of some novel pyrazole derivatives as potent antimicrobial agents, Org. Chem: J. 9 (2013) 414-424.
39. Shawkat A. Abdel-Mohsen, Synthesis, reactions and antimicrobial activity of 2-amino-4-(8-quinol-5-yl)-1-(p-tolyl)-pyrrole-3-carbonitrile, Bull. Korean Chem. Soc. 26 (2005) 719-728.
40. R. Mallikarjuna Rao, G. Nagaraja Reddy, J. Sreeramulu, Synthesis of some new pyrazolo-pyrazole derivatives containing indoles with antimicrobial activity, Der Pharma Chem. 3 (2011) 301-309.
41. R. Mallikarjuna Rao, M. Musthak Ahamad, J. Sreeramulu, Synthesis and antimicrobial activity of linked heterocycles containing pyrazolyle-indole derivatives, J. Chem. Pharm. Res. 5 (2012) 1518-1521.
42. R. Mallikarjuna Rao, J. Sreeramulu, L.K. Ravindranath, G. Nagaraja Reddy, K. Hanumanthurayudu, G. Nageswara Reddy, A. Jayaraju, P. Madhusudhan, Synthesis and biological screening of some pyridine e pyrrole derivatives of pyrazolo[3, 4-c]pyrazoles, J. Chem. Pharm. Res. 4 (2012) 272-278.
43. S.K. Chunduru, C.A. Benetatos, T.J. Nitz, T.R: Baley, Methods for the treatment and prophylaxis of hepatitis C viral infections and associated diseases using NS4B-inhibiting compounds and compositions, Patent WO2005051318, 2005.
44. G. Puerstinger, S.S. Bondy, E.D. Dowdy, C.U. Kim, D.A. Oare, J. Neyts, V. Zia, Preparation of imidazo [4, 5-c]pyridine derivatives as antiviral agents.
45. R. Silverman, Antiviral agents that activate RNase L, Patent WO 2007127212, 2007.
46. M.J. Costanzo, S.C. Yabut, B. Tounge, B. Maryanoff, H. Zhang, Spiropiperidines for use as thriptase inhibitors, Patent WO2009067202, 2009.
47. K. Kadoshima-Yamaoka, M. Goto, M. Murakawa, R. Yoshioka, Y. Tanaka, H. Inoue, H. Murafuji, S. Kanki, Y. Hayashi, K. Nagahira, A. Ogata, T. Nakatsuka, Y. Fukuda, ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-a level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice, Eur. J. Pharm. 613 (2009) 163-166.
48. M. Goto, Y. Tanaka, M. Murakawa, K. Kadoshima-Yamaoka, H. Inoue, H. Murafuji, A. Nagahira, S. Kanki, Y. Hayashi, K. Nagahira, A. Ogata, K. Miura, T. Nakatsuka, K. Chamoto, Y. Fukuda, T. Nishimura, Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice, Int. Immunopharm. 9 (2009) 1347-1413.
49. C. Yu-Chian Chen, De novo design of novel selective COX-2 inhibitors: from virtual screening to pharmacophore analysis, J. Taiwan Int. Chem. Eng. 40 (2009) 55-69.
50. P.J. Conn, C.W. Lindsley, C.R. Hopkins, C.M. Niswender, R.D. Gogliotti, J.M. Salovich, D.W. Engers, Y. Cheung, Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene abd phirazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction.
51. X. Yu, W. Zhang, A. Oldham, E. Buxton, S. Patel, N. Nghi, D. Tran, T.H. Lanthorn, C. Bomont, Z. Shi, Q. Liu, Discovery and characterization of potent small molecules inhibitors of the high affinity praline transporter, Neurosci. Lett. 451 (2009) 212-216.
52. O. Tormakangas, G. Wohlfahrt, H. Salo, R.D. Ramasubramanian, P.K. Patra, A.E. Martin, T. Heikkinen, A. Vesalainen, A. Moilanen, A. Karjalainen, Androgen receptor modulating carboxamides, Patent WO2012143599, 2012.
53. D.E. John, B. Hartzoulakis, S. Edwards, Thieno [2, 3-c]pyrazoles for use as potassium channel inhibitors Patent WO2013072693 A1,2013.
54. L. Ashcraft, Bergnes, S. Collibee, C. Chuang, J. Gardina, B. Morgan, et al., Certain amino-pyridazines, compositions thereof, and methods of their use, Patent WO2011133882, 2011.
55. D.C. Brookings, M.D. Calmiano, E.O. Gallimore, H.T. Horsely, M.C. Hutchings, J.A. Johnson, B. Kroeplien, F.C. Lecomte, M.A. Lowe, T.J. Norman, J.R. Porter, J.R. Quincey, TNF-alpha modulating benzamidazoles, Patent WO2013186229, 2013.
56. Z. Nie, R. Chen, M. Kono, B. Lam, M. Lardy, S. Reddy, S. Wilkins, Substituted 6-aza-isoindolin-1-one derivatives, Patent WO2012177714, 2012.
57. K. Kadoshima-Yamaoka, M. Murakawa, M. Goto, Y. Tanaka, H. Inoue, H. Murafuji, A. Nagahira, Y. Hayashi, K. Nagahira, K. Miura, T. Nakatsuka, K. Chamoto, Y. Fukuda, T. Nishimura, ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-production by mouse activated T lymphocytes, Immunol. Lett. 122 (2009) 193-197.
58. G.A. Demopulos, G.A. Gaitanaris, R. Ciccocioppo, Treatment of addiction and impulse-control disorders using PDE7 inhibitors, Patent WO2013176877, 2013.
59. H.G. Schwarz, S. Gassmann, K.H. Kuck, P. Dahmen, U. Wachen-Dorf-Neumann, S. Carbonne, S. Gary, C. Steele, A. Villier, J.P. Vors, Fungicide N-cyclopropylsulfonylamide derivatives, Patent WO2007113327, 2007.
60. J.N. Greul, H.G. Schwarz, A. Voerste, O. Malsam, Nematocide N-cyclopropylsulfonylamide derivatives, Patent WO2013010758, 2013.